Increased fertility and improved fetal development drug
Abstract
A method for increasing the fertility of a female mammal comprising administering to said female mammal an efficacious amount of tagatose. A method for promoting healthy fetal development in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose. A method for increasing the birth weight of a fetus in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose. A method for reducing excessive food intake of a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for increasing the fertility of a female mammal comprising administering to said female mammal an efficacious amount of tagatose.
2 . The method of claim 1 wherein the mammal is a human.
3 . The method of claim 1 wherein from 100-2000 mg/kg body weight/day is administered to said mammal.
4 . The method of claim 1 wherein the prescribed dose is taken every day.
5 . The method of claim 1 wherein the prescribed dose is taken every other day.
6 . The method of claim 1 wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.
7 . A method for promoting healthy fetal development in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.
8 . The method of claim 7 wherein the mammal is a human.
9 . The method of claim 7 wherein from 100-2000 mg/kg body weight/day is administered to said mammal.
10 . The method of claim 7 wherein the prescribed dose is taken every day.
11 . The method of claim 7 wherein the prescribed dose is taken every other day.
12 . The method of claim 1 wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.
13 . A method for increasing the birth weight of a fetus in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.
14 . The method of claim 13 wherein the mammal is a human.
15 . The method of claim 13 wherein from 100-2000 mg/kg body weight/day is administered to said mammal.
16 . The method of claim 13 wherein the prescribed dose is taken every day.
17 . The method of claim 13 wherein the prescribed dose is taken every other day.
18 . The method of claim 13 wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.
19 . A method for reducing excessive food intake of a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.
20 . The method of claim 19 wherein the mammal is a human.
21 . The method of claim 19 wherein from 100-2000 mg/kg body weight/day is administered to said mammal.
22 . The method of claim 19 wherein the prescribed dose is taken every day.
23 . The method of claim 19 wherein the prescribed dose is taken every other day.
24 . The method of claim 19 wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.Join the waitlist — get patent alerts
Track US2001020008A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.